Brancaster Pharma Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the Patient Information Leaflet (PIL) included in the cartons for the batches referenced in the notification was released with an outdated version.
Actualités réglementaires23 août 2026•1 min de lecture
Brancaster Pharma reports outdated PIL on notified batches
Brancaster Pharma informed the MHRA that cartons for the listed batches were supplied with an outdated Patient Information Leaflet.
Compilé par l'équipe PharmaCountry · Source : MHRA
Sujets :#Patient Information Leaflet#batch notification#regulatory compliance#pharmaceutical labeling#MHRA
Évaluations
(0)
(0)
(0)
(0)
(0)
Plus d'articles
Voir tous les articlesRecherches & Rapports
Global Finished Dosage Manufacturing Landscape 2026
5 oct. 2026
Actualités réglementairesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept. 2026
Laissez votre note